Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

As a result of the rapidly-spreading Omicron variant, last week saw the biggest spike in Covid case numbers since records began in March 2020, with 183,037 positive tests reported in the 24 hours to ...

In a recent review published in Nature Reviews Bioengineering, researchers assessed the changing landscape of lateral flow tests (LFTs), and the development of next-generation LFTs based on lessons ...

In our best practices blog, we explore how lateral flow assay design affects test performance. Read on to gain a deeper understanding of the development process, enabling you to streamline the ...

Please provide your email address to receive an email when new articles are posted on . The only available self-test for HIV was approved by the FDA in 2012. Since then, no company has applied for FDA ...

Dublin, Dec. 12, 2025 (GLOBE NEWSWIRE) -- The "Lateral Flow Assay Components Market by Type, Application, Technique, End User, and Region - Global Forecast to 2030" has been added to ...

In this interview, News-Medical talks to Andre Alfaro from nanoComposix (now a Fortis Life Sciences Company) about the possibilities lateral flow assays offer in both the present and potential ...

SAN FRANCISCO, Nov. 27, 2025 /PRNewswire/ -- The global lateral flow assays market size is expected to reach USD 17.44 billion by 2033, registering a CAGR of 6.98% from 2025 to 2033, according to a ...

HATFIELD, Pa.--(BUSINESS WIRE)--Genisphere LLC has licensed its 3DNA® Signal Amplification technology to Chembio Diagnostics, Inc., a leader in point-of-care ("POC") diagnostic tests for infectious ...

The MarketWatch News Department was not involved in the creation of this content. DELRAY BEACH, Fla., Aug. 14, 2025 /PRNewswire/ -- The global Lateral Flow Assays Market, valued at US$7.93 billion in ...